Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 10:38 PM
Ignite Modification Date:
2025-12-25 @ 8:09 PM
NCT ID:
NCT02051335
Pre Assignment Details:
Participants with a diagnosis of Alzeimer's disease were enrolled equally in a 4 period, 4 treatment crossover study. Treatment A: Placebo, Treatment B: Donepezil, Treatment C: Roflumilast and Treatment D: Roflumilast + Donepezil. All participants received scopolamine on Day 1 of each treatment period.
Recruitment Details:
Participants took part in the study at 1 investigative site in the United Kingdom from 16 January 2014 to 17 May 2014.
Study:
NCT02051335
Study Brief:
Results Section:
NCT02051335